<DOC>
	<DOCNO>NCT00002567</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . Combining chemotherapy peripheral stem cell transplantation may allow doctor give high dos chemotherapy drug kill cancer cell . PURPOSE : Phase II trial study effectiveness high-dose radiation therapy etoposide follow peripheral stem cell transplantation treat patient acute leukemia .</brief_summary>
	<brief_title>High-Dose Chemotherapy Radiation Therapy Followed Peripheral Stem Cell Transplantation Treating Patients With Acute Leukemia Remission</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate efficacy myeloablative total-body irradiation etoposide follow autologous peripheral blood stem cell ( PBSC ) transplantation prolong disease-free survival patient acute leukemia . II . Investigate ability growth factor-primed PBSC provide hematopoietic reconstitution follow myeloablative therapy . OUTLINE : Patients treat Regimen A , Regimen B . Regimen A : Stem Cell Mobilization . Granulocyte Colony Stimulating Factor ( Amgen ) , G-CSF , NSC-614629 . Regimen B : Radiotherapy Myeloablative Chemotherapy Hematopoietic Rescue . Total-Body Irradiation , TBI ( high-energy electron use lung boost ) ; Etoposide , VP-16 , NSC-141540 ; Peripheral Blood Stem Cells , PBSC ; G-CSF . PROJECTED ACCRUAL : Up 45 patient study approximately 3 year .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Previously diagnose acute leukemia one follow category : Acute myelogenous leukemia ( subtype ) first subsequent remission Ph+ acute lymphoblastic leukemia ( ALL ) first great remission Ph ALL second subsequent remission Cellular marrow morphologic evidence residual leukemia within approximately 2 week cryopreservation Negative CSF cytology require ALL patient Allogeneic marrow transplant consider patient age 55 healthy HLAidentical family member available PATIENT CHARACTERISTICS : Age : Over 16 65 Performance status : Not specify Hematopoietic : WBC great 3,500/mm3 Platelet count great 100,000/mm3 Hepatic : Bilirubin le 2.0 mg/dl Renal : Creatinine great 1.5 mg/dl OR Creatinine clearance least 60 ml/min Cardiovascular : LVEF least 50 % MUGA normal echocardiogram Pulmonary : DLCO least 50 % predict Other : HIV seronegative No uncontrolled infection Negative pregnancy test require fertile woman PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>adult acute myeloid leukemia remission</keyword>
	<keyword>adult acute lymphoblastic leukemia remission</keyword>
	<keyword>adult acute erythroid leukemia ( M6 )</keyword>
	<keyword>adult acute myeloblastic leukemia without maturation ( M1 )</keyword>
	<keyword>adult acute myeloblastic leukemia maturation ( M2 )</keyword>
	<keyword>adult acute promyelocytic leukemia ( M3 )</keyword>
	<keyword>adult acute myelomonocytic leukemia ( M4 )</keyword>
	<keyword>adult acute monoblastic leukemia ( M5a )</keyword>
	<keyword>adult acute megakaryoblastic leukemia ( M7 )</keyword>
	<keyword>adult acute monocytic leukemia ( M5b )</keyword>
	<keyword>bone marrow ablation</keyword>
	<keyword>adult acute minimally differentiate myeloid leukemia ( M0 )</keyword>
</DOC>